PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.

ABSTRACT: Nonviral integrating vectors can be used for expression of therapeutic genes. piggyBac (PB), a transposon/transposase system, has been used to efficiently generate induced pluripotent stems cells from somatic cells, without genetic alteration. In this paper, we apply PB transposition to express a chimeric antigen receptor (CAR) in primary human T cells. We demonstrate that T cells electroporated to introduce the PB transposon and transposase stably express CD19-specific CAR and when cultured on CD19(+) artificial antigen-presenting cells, numerically expand in a CAR-dependent manner, display a phenotype associated with both memory and effector T cell populations, and exhibit CD19-dependent killing of tumor targets. Integration of the PB transposon expressing CAR was not associated with gen

SUBMITTER: Manuri PV 

PROVIDER: S-EPMC2938363 | biostudies-literature | 2010 Apr

REPOSITORIES: biostudies-literature